Literature DB >> 2467097

Sympathetic hyperactivity in early stages of hypertension: the Ann Arbor data set.

S Julius1, N Schork, A Schork.   

Abstract

Patients with borderline hypertension frequently have a hyperkinetic circulation that is neurogenic and can be normalized with autonomic blockade of the heart. The abnormality is of central nervous system origin and due to increased sympathetic stimulation and decreased vagal inhibition of the heart. A subset of patients characterized by high plasma renin and norepinephrine values clearly has a neurogenic hypertension since their blood pressure becomes normal after cardiac blockade and vascular alpha-adrenergic blockade. Since many patients with borderline hypertension have a high cardiac output, and the majority of patients with more advanced hypertension have increased vascular resistance, two questions arise. Is the "hyperkinetic state" a special condition unrelated to established hypertension or is there, in the course of hypertension, a transition from "high output" to "high resistance" state? The literature strongly suggests that patients with hyperkinetic borderline hypertension later proceed to develop the established high resistance form of hypertension. The most likely mechanism for this transition is a change in cardiac and vascular responsiveness due to prolonged excess sympathetic stimulation combined with structural pressure-induced changes in these organs. This analysis of the events in the course of hypertension is of necessity based on an arbitrary definition of the hyperkinetic state usually set at a cardiac index at least two standard deviations above the normal mean. A bivariate analysis of our data (268 normotensive and 186 patients with borderline hypertension) suggests that there indeed are two different populations in this data set. Based on this commingling analysis, the occurrence of a hyperkinetic state was five-fold as frequent in patients with borderline hypertension than in the normotensive population.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 2467097

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  President's address: salt-too much of a good thing?

Authors:  Robert G Luke
Journal:  Trans Am Clin Climatol Assoc       Date:  2007

2.  Examining the association between perceived discrimination and heart rate variability in African Americans.

Authors:  LaBarron K Hill; Lori S Hoggard; Ashley S Richmond; DeLeon L Gray; Dewayne P Williams; Julian F Thayer
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2017-01

Review 3.  The fourth-generation Calcium channel blocker: cilnidipine.

Authors:  K Sarat Chandra; G Ramesh
Journal:  Indian Heart J       Date:  2013-12

4.  Adrenocortical effects of caffeine at rest and during mental stress in borderline hypertensive men.

Authors:  M al'Absi; W R Lovallo; G A Pincomb; B H Sung; M F Wilson
Journal:  Int J Behav Med       Date:  1995

Review 5.  Stress and Addiction: When a Robust Stress Response Indicates Resiliency.

Authors:  Mustafa alʼAbsi
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

Review 6.  Salt sensitivity, endogenous ouabain and hypertension.

Authors:  John M Hamlyn; Mordecai P Blaustein
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-01       Impact factor: 2.894

7.  A randomized controlled study on the effects of bisoprolol and atenolol on sympathetic nervous activity and central aortic pressure in patients with essential hypertension.

Authors:  Wei-Jun Zhou; Ren-Ying Wang; Yan Li; Dong-Rui Chen; Er-Zhen Chen; Ding-Liang Zhu; Ping-Jin Gao
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.